Theravance Biopharma OverviewTheravance Biopharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for TBPH.
Quarterly EBIT
-$9.48M
↑ 34.3% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
$82.08M
↑ 277.2% YoY
Trailing 12 months ending Mar 31, 2026
Theravance Biopharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for TBPH.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026